- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/02 - Halogenated hydrocarbons
Patent holdings for IPC class A61K 31/02
Total number of patents in this class: 327
10-year publication summary
|
18
|
22
|
24
|
31
|
21
|
29
|
25
|
29
|
32
|
10
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novaliq GmbH | 165 |
42 |
| Amarin Pharmaceuticals Ireland Limited | 267 |
22 |
| NuVox Pharma, LLC | 26 |
18 |
| Arvinas Operations, Inc. | 165 |
9 |
| Vapogenix, Inc. | 15 |
7 |
| The Regents of the University of California | 18943 |
6 |
| DSM IP Assets B.V. | 5856 |
6 |
| The Board of Regents of the University of Texas System | 2043 |
6 |
| Abbvie Inc. | 1808 |
4 |
| Bioventures, LLC | 201 |
4 |
| Hoffmann-La Roche Inc. | 3060 |
3 |
| Genentech, Inc. | 3742 |
3 |
| The Johns Hopkins University | 5377 |
3 |
| University of Florida Research Foundation, Inc. | 3883 |
3 |
| Northwestern University | 3112 |
3 |
| Altimmune UK Limited | 23 |
3 |
| Braincool AB | 38 |
3 |
| Children's Medical Center Corporation | 1780 |
3 |
| National University Corporation Tokyo Medical and Dental University | 518 |
3 |
| Oxygen Biotherapeutics, Inc. | 11 |
3 |
| Other owners | 173 |